Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001228572 | SCV001400975 | pathogenic | Tumor predisposition syndrome 3 | 2023-05-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val434*) in the POT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 955861). This variant has not been reported in the literature in individuals affected with POT1-related conditions. |
Ambry Genetics | RCV002379874 | SCV002691162 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-06-27 | criteria provided, single submitter | clinical testing | The c.1300delG pathogenic mutation, located in coding exon 10 of the POT1 gene, results from a deletion of one nucleotide at nucleotide position 1300, causing a translational frameshift with a predicted alternate stop codon (p.V434*). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |